ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Could Improve Designation Review Consistency; Rare Disease Drug Development Challenges Continue
December 02, 2018The Food and Drug Administration designates some drugs as "orphan drugs," which allows manufacturers to obtain incentives (like tax breaks) for developing drugs that treat rare diseases. But we found that FDA reviewers don’t always include all the require
Pharma Sources Insight January 2025
